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Multimodal cancer therapies exploit either additive or synergistic effects arising from the generation of different active species for improving the therapeutic efficacy.1 In this frame, the spatio-temporal control of the bio-active agents represents a challenging objective since it allows, in principle, maximization of the therapeutic action and minimization of side effects.2 Light represents a powerful tool for the rapid introduction of active species in a biological environment, mimicking an “optical microsyringe” with exquisite control of three main factors such as site, timing and dosage, which are determining for the therapeutic outcome.3-5 In addition, photochemical triggering offers the great benefit of not perturbing the physiological values of parameters such as temperature, pH and ionic strength, fundamental prerequisite for biomedical applications. These unique features make the photoactivated systems a powerful arsenal in the burgeoning field of nanomedicine with intriguing potential to tackle cancer diseases in a noninvasive way.3-7
Multidrug resistance (MDR), the major factor in the failure of many forms of chemotherapy,8 calls for a shift of attention to alternative treatment modalities. At this regard, the light-controlled generation of reactive oxygen species (ROS) and reactive nitrogen oxygen species (RNOS) such as singlet oxygen (1O2) and nitric oxide (NO) by using appropriate photochemical precursors represents a fascinating and unconventional strategy.
1O2 is the key species in photodynamic therapy (PDT), a well-established therapeutic modality for the treatment of malignant lesions in humans. It implies the combined use of visible light, a non-toxic photosensitizing dye (PS) and the molecular oxygen.9 The PS generally belongs to the class of porphyrins and phthalocyanines10 and is administered by intravenous, intraperitoneal or topical route. It accumulates preferentially into the tumor cells as compared with the normal cells and its intracellular distribution is depending on its structure.11 Illumination of the tumoral area with an opportune dose of appropriate wavelength light, leads to the population of the lowest and long-lived excited triplet state of the PS. The return of the system to the ground state occurs mainly by energy transfer to molecular oxygen, generating the highly reactive 1O2 which induces selective tumor cell and tumor tissue destruction through a number of mechanisms.12
Nitric oxide (NO) is an important gaseous endogenous messenger which plays a variety of roles in the human physiology and pathophysiology.13 NO contributes to maintain micro and macrovascular homeostasis inducing vasodilation, inhibition of platelet aggregation, modulation of platelet and leukocyte adherence to vessels, and inhibition of smooth muscle cell proliferation.14 In the central nervous system it is implicated in neural signaling, neurotoxicity, neuroprotection, synaptic plasticity and modulation of behavioral pathways.15 Peripherally NO modulates a number of reflexes by acting as neurotransmitter at the endings of non-adrenergic non-cholinergic nerves.15 NO is also one of the final effectors in the immune system, where it triggers tumoricidal, antimicrobial or antiparasitic actions.16 Indeed, NO plays important roles in the biology of tumors and in the inflammation processes.17,18 Therefore, great attention has been paid to products able to release NO under physiological conditions as potential drugs to fight a variety of diseases.19,20 NO-photodonors, namely molecules capable of producing NO under the action of the light, represent a particular class of these compounds.21,22 They allow an accurate control of the timing, location and dosage of NO-release. This aspect is very important since NO can be therapeutic or toxic (double edged sword) depending on the doses.23


Scheme 1. Molecular structures of the conjugate 1, the model compounds 2 and 3, and the polymer carrier 4.

The combination of 1O2 and NO represents a very appealing strategy in view of multimodal therapeutic systems. 1O2 and NO share in fact several important features such as: i) small size and absence of charge, ii) capability to attack biological substrates of different nature (i.e., lipids, proteins, and DNA), iii) absence of multidrug resistance, iv) confinement of their action to short distances from the production site inside the cells (< 20 nm for 1O2 and < 200 µm for NO), due to their short lifetime, reducing systemic toxicity issues common to many conventional drugs. Besides, since NO photorelease is independent from O2 availability, it very well complements PDT at the onset of hypoxic conditions, typical for some tumors, where PDT may fail.







Scheme 2. Synthesis of the conjugate 1 and the model compounds 2 and 3. Reagents and conditions: i) 3c, refluxing glacial CH3COOH, 20 hrs; ii) 1-bromopropane, glacial CH3COOH, 120 °C (closed vessel), 20 hrs; iii) CH3NH2 33% in absolute EtOH, Na2CO3, 70 °C, 36 hrs (closed vessel); iv) 1,3-dibromopropane, K2CO3, refluxing CH3CN, 5 days; v) N-methylpropylamine, Na2CO3, absolute EtOH, 70 °C, 36 hrs (closed vessel).
In search of a viable strategy to construct a molecular hybrid able to display fluorescence properties associated to the simultaneous photogeneration of 1O2 and NO we have deliberately chosen a nitroaniline derivative bearing a CF3 substituent in the ortho position with respect to the nitro group and a tetra-pyridyl porphyrin as suitable chromogenic units, respectively. We have demonstrated that such a class of nitroaniline-like chromophores are suitable NO photodonors as they satisfy several prerequisites for bio-applications including excitation with visible light and formation of non-toxic side photoproducts.26,27 The twisted conformation adopted by the nitro group with respect to the aromatic plane is crucial for the NO photorelease. Similarly to other nitroaromatics having the same molecular conformation, the mechanism of NO release involves an initial nitro-to-nitrite photorearrangement followed by cleavage of the O-NO bond.28 Besides, pyridyl porphyrins derivatives are good red photoemitters, excellent 1O2 PS and, in addition, they can be ad-hoc derivatized via simple synthetic procedures.29
The rationale behind the choice of the above chromogenic components has its root in our previous works in which we have demonstrated that the non-covalent assembling of porphyrin centers and nitroaniline-based NO photodonors in a restricted region of space after incorporation in micelles,30 nanoparticles31 and host-guest complexes,32 does not influence the photochemical behavior of both chromophores. Note that, in contrast to non-photoresponsive compounds, the preservation of the photobehavior of independent photoactive components after their covalent linking is not a "trivial result". In most cases, the response to light of the single photoactive units located in a so close proximity can be considerably influenced, in both nature and efficiency, by the occurrence of competitive photoprocesses (i.e., photoinduced energy and/or electron transfer, non-radiative deactivation, etc.), which do not allow the individual components to work in parallel after light absorption. Taking into account these considerations, we have synthesized the conjugate 1 and the model compounds 2 and 3 according to the synthetic steps illustrated in Scheme 2. Reaction of 3c and of 1-bromopropane with an excess of porphyrin 1a in glacial acetic acid solution gave rise to the compounds 1 and 2 in poor yields, after flash chromatography purification. The products 3b and 3 were easily obtained by treatment of the commercial 4-chloro-1-nitro-2-(trifluoromethyl)benzene (3a) with methylamine and N-methylpropylamine respectively, in absolute ethanol solution in the presence of Na2CO3. Intermediate 3c was prepared by refluxing in acetonitrile 1,3-dibromopropane and 3b in the presence of K2CO3. 
Spectroscopic and photochemical properties
Fig. 1A shows the absorption and fluorescence emission spectra of the molecular hybrid 1 and the related model compounds in methanol solution. The absorption profile of 1 reflects fairly well that of an equimolar mixture of the model compounds 2 and 3, with an experimental error of about 10 %, accounting for only a weak interaction between the two chromophoric units in the ground state. Besides, 1 exhibits the typical dual band  fluorescence emission of the porphyrin moiety, analogously to that observed for an optically matched solution of the model compound 2. We obtained a fluorescence quantum yield f = 0.06 for 1 and 2, a value in the range reported for other pyridyl porphyrin derivatives.33 This result suggests that the porphyrin core retains its emissive properties after the covalent linkage with the nitroaniline appendage. 
Compound 1 is totally insoluble in both phosphate-buffered aqueous solution and in DMEM medium. However, compound 1 was slightly soluble in water containing 1% DMSO but unfortunately the presence of large aggregates precluded fluorescence. Focusing on solubility and aggregation issues in aqueous medium, cyclodextrin (CD) polymers offer the possibility of guest interaction with diverse binding sites, i.e. within the 3D macromolecular network and the CD cavities, thereby enhancing the apparent solubility and regulating the self-association tendency of drugs.34 On these basis we used polymer 4 (see Scheme 1) as a suitable nanocarrier. Polymer 4 consists of β-CD units interconnected by epichlorohydrin spacers to form glyceryl cross-linked β-CD polymer. This polymer is well tolerated in vivo35 and highly soluble in water where it exists under the form of nanoparticles (NPs) of ca. 25 nm in diameter.36 Due to the presence of different hydrophobic nanodomains these NPs are able to entrap a variety of guests34,37,38 with enhanced stability constants and payloads as compared with the unmodified β-CD.

Fig. 2 (A) Transient absorption spectra observed 0.1 µs after 532 nm laser excitation (E532 ~ 12 mJ/ pulse) of Ar-saturated and optically matched methanol solutions of 1 () and 2 (). The inset shows the decay trace monitored at 450 nm and the related first-order fitting. (B) Transient absorption spectra observed 1 µs (), 390 µs (), 850 µs () and 1700 µs () after 532 nm laser excitation (E532 ~ 12 mJ/ pulse) of Ar-saturated aqueous dispersions of 4 in phosphate buffer 10 mM pH 7.4 in the presence of 1. The inset shows the decay trace monitored at 440 nm and the related first-order fitting. [1] = 3.3 µM; [4] = 4 mg mL-1; 25 °C.
Compound 1 becomes fairly soluble in the presence of aqueous dispersion of 4. As shown in Fig. 1B, both the absorption and the emission profiles (spectra a and c) were very similar to those observed in methanol confirming the effective encapsulation of 1 within 4, mainly under its monomeric form. The fluorescence quantum yield was even higher than in methanol solution, being f = 0.09. Dynamic light scattering measurements indicate the average hydrodynamic diameters of ca. 35 nm for the NPs entrapping 1 (a, inset Fig. 1B). This value is slightly larger than that observed for the empty NPs (ca. 25 nm)36 and in excellent agreement with that found for the same carrier entrapping chromophores of similar molecular sizes as 1.34,37,38 Interestingly, the absorption  and emission characteristics (b and d in Fig. 1B) together with NPs sizes (b in the inset of Fig. 1B) were preserved quite well in DMEM medium where we obtained an emission quantum yield f = 0.07 and a hydrodynamic diameter of ca. 33 nm. 
The excited triplet state of the porphyrins is the key transient intermediate for the photosensitization of 1O2 and its effective generation is thus crucial for the photodynamic action.9 Laser flash photolysis with nanosecond time-resolution is a powerful tool for obtaining spectroscopic and kinetic features of excited triplets of porphyrins since these transient species exhibit very intense absorptions in the visible region and possess lifetimes falling in the microsecond time scale.39 Fig. 2A shows that laser excitation of compound 1 in methanol results in the formation of a transient absorption with a maximum at ca. 450 nm and a bleaching due to the Soret ground-state absorption. This species which decays mono-exponentially with a lifetime of ca. 20 µs (inset Fig. 2A), is virtually the same to that obtained upon laser excitation of the model compound 2 (which decays with similar lifetime) and can be safely attributed to the lowest excited triplet state of the porphyrin core.39

Fig. 1 (A) Absorption spectra of methanol solutions of 1 (a), 2 (b) and 3 (c). Fluorescence emission spectra (exc = 505 nm) of methanol solutions of 1 (d) and 2 (e). [1] = [2] = [3] = 3.3 µM; T = 25°C. (B) Absorption and fluorescence emission spectra of 1 in the presence of dispersions of 4 in aqueous phosphate buffer 10 mM pH 7.4 (a and c) and DMEM medium (b and d). The inset shows the hydrodynamic diameter for dispersions of 4 in the presence of 1 in aqueous phosphate buffer 10 mM pH 7.4 (a) and DMEM medium (b). [1] = 3.3 µM; [4] = 4 mg mL-1; 25 °C.
Analogously to what observed for the fluorescence emission, the presence of the nitroaniline-derivative appendage does not influence the efficiency of the triplet population. In fact, since the two samples were optically matched at the excitation wavelength and the laser energy used was the same, the intensity of the transient absorption is directly related to the triplet quantum yield T. We obtained a value for T of 0.85 (see experimental section), in excellent agreement with other tetrapyridyl porphyrin derivatives.[33] 

Fig. 4 NO release profiles observed upon irradiation (exc = 405 nm) of aqueous dispersion of 4 in the presence of either 1 (a) or the model compound 3 (b). [1] = [3] = 3.3 µM; [4] = 4 mg mL-1; Phosphate buffer 10 mM, pH 7.4, 25°C. The data are corrected for the different fraction of absorbed photons by 1 and the model compound 3, at the excitation wavelength. 
.
The triplet state is also effectively populated when 1 is encapsulated in the NPs of the polymer carrier 4 in aqueous solution. Fig. 2B shows the transient absorption spectra obtained under these conditions and recorded at different delay times with respect to the initial laser pulse. Apart from a slight blue shift in the absorption maximum, the spectrum taken at the shortest delay time shows a profile very similar to that observed in methanol solution. The time evolution of the absorption reveals that no new transient is formed concurrently to the triplet decay, ruling out any possible reaction of this species with the NPs. The excited triplet state decays mono-exponentially with a triplet lifetime of ca. 1000 µs (inset Fig. 2B), more than one order of magnitude longer than that observed in the organic solvent. The lengthening of the triplet decay observed is quite common upon incorporation of chromophores hosted in systems such as micelles, liposomes and CDs and is usually related to the protection exerted by the host cage against external quenching impurities, to a perturbation of the inter-system crossing process to the ground state, or to both.40
Energy transfer from the triplet of 1 to molecular oxygen results in the photogeneration of 1O2. Time-resolved near-infrared luminescence with sub-microsecond time resolution is the most suitable technique to unequivocally demonstrate the generation of singlet oxygen, 1O2. This species, in fact, exhibits a typical luminescence signal at 1.27 m with a lifetime ranging in the microseconds time-scale.41 We have examined the singlet oxygen produced by energy transfer from 1 and the model compound 2 to molecular O2, in partially deuterated (80% D2O) aqueous dispersions of the carrier 4. Fig. 3 shows the typical phosphorescence signal at 1270 nm observed for 1 and the model compound 2. In both cases, the kinetic analysis of the decay traces gives a lifetime of ca. 40 µs, consistent with the reported value in the solvent used.41
Analogously to what observed for the precursor triplet state, the quantum yield of 1O2 () for 1 was basically the same to that determined for the model 2. We obtained a value for  = 0.55 (see experimental) for both compounds, in excellent agreement to that reported for monocationic pyridyl porphyrins.29
The NO photorelease properties of the conjugate 1 are demonstrated by the direct and real-time monitoring of this transient species using an ultrasensitive NO electrode which directly detects NO with nM concentration sensitivity by an amperometric technique.42 The results illustrated in Fig. 4 provide evidence that the molecular hybrid 1 and the model compound 3 are stable in the dark but supply NO exclusively upon illumination with visible light. Note that, the rate for the NO photorelease was ca. 50 nM s-1 for both compounds suggesting that the porphyrin chromophore does not influence the capability of the NO photorelease in the conjugate.
Cell imaging and viability assay
The suitability of the multifunctional molecular conjugate 1 for cell fluorescence imaging and bimodal phototoxicity was demonstrated by in vitro experiments performed with A375 cells, a human amelanotic melanoma cell line. The cell uptake of 1 was determined after 4 h of incubation of a DMEM suspension of the carrier 4 in the presence of 1, using fluorescence microscopy (Fig. 5). The typical porphyrin-associated fluorescence reveals that 1 accumulated in the cytoplasm of the melanoma cells, observed as red fluorescent spots, but no nucleus associated fluorescence was observed. Fluorescence examination demonstrated the absence of obvious cell toxicity and of nuclear fragmentation, a marker of cell apoptosis, by DAPI staining.

Fig. 3 Representative decay kinetic and related first-order fitting of 1O2 observed upon 532 nm laser excitation (E532 ~ 12 mJ/ pulse) of aqueous dispersion (80% D2O) of 4 in the presence of either 1 (A) or the model compound 2 (B). [1] = [2]  = 3.3 µM; [4] = 4 mg mL-1; Phosphate buffer 10 mM, pH 7.4, 25°C.

Fig 5 Evaluation of the uptake of 1 by A375 melanoma cells. (A) Transmission microscopy. (B) Merging images of the cells analysed with a porphyrin and a DAPI emission filters, respectively, indicating accumulation of 1 in cells (red spots). [1] = 3.3 µM; [4] = 4 mg mL-1; 25°C.
.
To validate the feasibility of using this new molecular hybrid for bimodal phototherapeutic activity, the melanoma cells were incubated under different experimental conditions and were either kept in the dark or irradiated with visible light in the range 400-800 nm. Cell cytotoxicity was determined using the MTT assay 4 h after the completion of the irradiation. The results illustrated in Fig. 6 show that all samples displayed a low level of cytotoxicity in the dark, accounting for a good tolerance of the systems used. Besides, cells were not photosensitive in the absence of the photoactive compounds 1, 2 or 3. In contrast, considerable cell mortality was observed in the presence of these latter under illumination. In particular, the photoinduced mortality increased as a function of both the irradiation time and the concentration of the photoactive components. In all cases, the level of photodynamic inactivation induced by the conjugate 1 was higher as compared to the value observed with the model compounds 2 and 3 under the same experimental conditions. This result provides clear-cut evidence for the involvement of a bimodal photo-inactivation mechanism in neoplastic destruction, in which NO and 1O2 are envisaged to play a key role. 









All reagents were of the highest commercial grade available and were used without further purification. All solvents used (from Sigma-Aldrich) were analytical grade. Compounds 1a and 3a were purchased from Sigma-Aldrich. 1H and 13C NMR spectra were recorded on a Bruker Avance 300 at 300 and 75 MHz respectively, using SiMe4 as internal standard. Low resolution mass spectra were recorded with a Finnigan-Mat TSQ-700. High resolution mass spectra were recorded on a Bruker BioApex Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometer equipped with an Apollo I ESI source, a 4.7 T superconducting magnet, and a cylindrical infinity cell (Bruker Daltonics, Billerica, MA, USA). Melting points were determined with a capillary apparatus (Büchi 540). Flash column chromatography was performed on silica gel (Merck Kieselgel 60, 230-400 mesh ASTM), or on neutral aluminum oxide (Fluka Aluminum Oxide for Chromatography, 0.05-0.15 mm, Brockmann activity I). The progress of the reactions was monitored by thin layer chromatography (TLC) on 5 cm x 20 cm plates with a layer thickness of 0.2 mm. Organic solvents were removed under vacuum at 30 °C. Elemental analyses (C, H, N) of the target compounds 1 and 3 were performed by REDOX Snc Monza, and the results are within 0.4% of the theoretical values. The purity of compound 2 (> 97%) was assessed by HPLC. Analyses were performed on an Acquity Ultra Performance LCTM, Waters Corporation Milford MA, USA, equipped with BSM, SM, CM and PDA detector. The analytical column was a Phenomenex Synergi 4 µ, Max-RP, 150 x 2 mm. Compound was dissolved in CH3OH. The mobile phase consisted of CH3OH /water with 0.1% formic acid 50/50. HPLC retention time (tR) was obtained at flow rates of 0.3 mL min-1, and the column effluent was monitored at 236 and 420 nm.
N-methyl-4-nitro-3-(trifluoromethyl)aniline (3b). In a closed vessel 3a (5g, 22 mmol), 33% solution of CH3NH2 in absolute EtOH (10 eq.) and Na2CO3 (10 eq.) in 100 mL of absolute EtOH were stirred under heating at 70 °C for 36 hours. The mixture was allowed to reach room temperature, and then concentrated under reduced pressure. The residue was taken up with CH2Cl2, washed with water and brine, dried over Na2SO4 and concentrated under reduced pressure. The crude product was purified by flash chromatography on silica gel, eluent 40% CH2Cl2/PE, to afford the title product as a yellow solid (87%); mp (CCl4) 114-115 °C. 1H-NMR (CDCl3):  2.96 (3H, d, J = 5.1 Hz, CH3), 4.89 (1H, br signal, NH), 3.11 (3H, s, CH3N), 6.66 (1H, dd, J1 = 9.0 Hz, J2 = 2.4 Hz aromatic), 6.93 (1H, d, J = 2.4 Hz, aromatic), 8.05 (1H, d, J = 9.0 Hz, aromatic). 13C-NMR (CDCl3):  30.1, 110.87 (q, J = 6.75 Hz), 112.2, 122.3 (q, J = 271 Hz), 126.6 (q, J = 33 Hz), 129.2, 136.2, 152.8. MS CI (isobutane) (m/z): 221 [MH+].
N-(3-bromopropyl)-N-methyl-4-nitro-3-(trifluoromethyl)aniline (3c). In a 500 mL round bottom flask a mixture of 3b (3.3 g 15 mmol), 1,3-dibromopropane (10 eq.) and K2CO3 (3 eq.) was refluxed in 300 mL of CH3CN for 5 days. The mixture was allowed to reach room temperature and concentrated under reduced pressure. The residue was taken up with CH2Cl2, washed with water and brine, dried over Na2SO4 and concentrated under reduced pressure. The crude product was purified by flash chromatography on silica gel, eluent 30% CH2Cl2/PE, to afford the title product as a yellow solid (30%); mp (MeOH/H2O) 66.7 – 67.3 °C. 1H-NMR (CDCl3):  2,19 (2H, quintuplet, J = 6 Hz, CH2CH2CH2), 3.15 (3H, s, CH3), 3.46 (2H, t, J = 6 Hz, CH2N), 3.67 (2H, t, J = 6 Hz, CH2Br), 6.78 (1H, m, aromatic), 7.00 (1H, s, aromatic), 8.05 (1H, m, aromatic). 13C-NMR (CDCl3):  29.5, 30.3, 39.0, 50.6, 109.8 (q, J = 6.75 Hz), 112.3, 122.4 (q, J = 272 Hz), 126.5 (q, J = 32 Hz), 130.0, 135.6, 151.8. MS CI (isobutane) (m/z): 341/343 [MH+].
N-methyl-4-nitro-N-propyl-3-(trifluoromethyl)aniline (3). In a closed vessel 3a (1g, 4.4 mmol), N-methylpropylamine (10 eq.) and Na2CO3(10 eq.) in 40 mL of absolute EtOH were stirred under heating at 70 °C for 36 hours. The mixture was allowed to reach room temperature and concentrated under reduced pressure. The residue was taken up with CH2Cl2, washed with water and brine, dried over Na2SO4 and concentrated under reduced pressure. The crude product was purified by flash chromatography on silica gel, eluent 40% CH2Cl2/PE, to afford the title product as a yellow solid (70%); mp (H2O): 79.6 – 80.9 °C. 1H-NMR (CDCl3):  0.97 (3H, t, J = 7.5 Hz, CH2CH2CH3), 1.67 (2H, sextet, J = 7.5 Hz, CH2CH2CH3), 3.11 (3H, s, CH3N), 3.42 (2H, t, J = 7.5 Hz, CH2N), 6.70 (1H, dd, J1 = 9.3 Hz, J2 = 2.7 Hz aromatic), 6.93 (1H, d, J = 2.7 Hz, aromatic), 8.05 (1H, d, J = 9.3 Hz, aromatic).13C-NMR (CDCl3):  11.3, 20.1, 38.9, 54.3, 109.60 (q, J = 6.6 Hz), 112.0, 122.5 (q, J = 272 Hz), 126.48 (q, J = 33 Hz), 129.1, 131.3, 152.0. MS CI (isobutane) (m/z): 263 [MH+]. Anal. C,H,N. 
1-(3-methyl[4-nitro-3-(trifluoromethyl)phenyl]aminopropyl)-4-(10,15,20-tripyridin-4-ylporphyrin-5-yl)pyridinium bromide (1). In a 100 mL round bottom flask, 1a (0.5 g, 0.81 mmol) and 3c (0.5 eq.) were dissolved in 20 mL of glacial acetic acid and refluxed for 20 hours. The mixture was allowed to reach room temperature, and concentrated under reduced pressure. The residue was taken up with boiling methanol and filtered. The filtrate was concentrated under reduced pressure. The crude compound was purified by flash chromatography on neutral alumina, eluent 3 - 5 % CH3OH/CH2Cl2, to afford the title product as a dark red solid (16 %); mp > 300 °C. 1H-NMR (D6-DMSO):  -3.05 (2H, s, 2 NH, pyrroles), 2.61 (2H, quint, J = 7.5 Hz, CH2CH2CH2), 3.30 (3H, s, CH3N), 3.93 (2H, t, J = 7.5 Hz, CH2N), 5.07(2H, t, J = 7.5 Hz, CH2N+pyr), 7.21 (1H, s, aromatic), 7.24 (1H, d, J = 9 Hz aromatic), 8.20 (1H, d, J = 9 Hz, aromatic), 8.28 (6H, d, J = 6 Hz, aromatic), 8.94 – 9.11 (16H, m, aromatic), 9.59 (2H, d, J = 6 Hz, aromatic). HR-MS expected for C51H38F3N10O2 879.3125; found 879.3137. Anal. C,H,N.
1-propyl-4-(10,15,20-tripyridin-4-ylporphyrin-5-yl)pyridinium bromide (2). The product was obtained starting from 1a and 1-bromopropane with the procedure used for the preparation of 1. The crude compound was purified on neutral alumina column, eluent 3 - 5 % CH3OH/CH2Cl2, to give the expected product as a dark red solid (21%); mp > 300 °C, HPLC tR: 7.6 min. 1H-NMR (D6-DMSO):  -3.03 (2H, s, 2 NH, pyrroles), 1.21 (3H, t, J = 7.5 Hz), 2.31 (2H, sext, J = 7.5 Hz, CH2CH2CH3), 4.93 (2H, t, J = 7.5 Hz, CH2N+), 8.30 (6H, d, J = 6 Hz, aromatic), 8.96 – 9.13 (16H, m, aromatic), 9.57 (2H, d, J = 6 Hz, aromatic). HR-MS expected for C43H33N8 661.2822; found 661.2820.
The -CD polymer 4 was prepared by crosslinking -CD with epichlorohydrin, under strong alkaline conditions, following a previously described method.36
Sample preparation
Solution of 4 was prepared by stirring overnight 4 mg mL-1 of 4 in either aqueous phosphate buffer 10 mM at pH 7.4 or DMEM medium. Compounds 1, 2 and 3 were dissolved in methanol and slowly evaporated to form a thin film. These films were then hydrated with solutions of 1. The mixtures were stirred for 5 hours at 40 °C and then the final solutions were left to equilibrate at room temperature and filtered.
Instrumentation
Steady-state absorption, emission, and NPs sizes. UV/Vis absorption and fluorescence spectra were recorded with a thermostated HP-8452 diode array spectrophotometer and Fluorolog-2 (Model, F-111) spectrofluorimeter respectively. All measurements were performed in a thermostated quartz cell (1 cm path length, 3 mL capacity). NPs sizes were measured by a dynamic light scattering Horiba LS 550 apparatus equipped with a diode laser with a wavelength of 650 nm.
Fluorescence images were acquired using a Leica DMRB fluorescence microscope (Leica Microsystems Srl, Milan, Italy) equipped with a computer-assisted Nikon digital camera (Nital SpA, Turin, Italy).
Laser flash photolysis. All of the samples were excited with the second harmonic of Nd–YAG Continuum Surelite II–10 laser (532 nm, 6 ns FWHM), using quartz cells with a path length of 1.0 cm. The excited solutions were analyzed with a Luzchem Research mLFP–111 apparatus with an orthogonal pump/probe configuration. The probe source was a ceramic xenon lamp coupled to quartz fiber-optic cables. The laser pulse and the mLFP–111 system were synchronized by a Tektronix TDS 3032 digitizer, operating in pre-trigger mode. The signals from a compact Hamamatsu photomultiplier were initially captured by the digitizer and then transferred to a personal computer, controlled by Luzchem Research software operating in the National Instruments LabView 5.1 environment. The solutions were deoxygenated by bubbling with a vigorous and constant flux of pure argon (previously saturated with solvent). In all of these experiments, the solutions were renewed after each laser shot (in a flow cell of 1 cm optical path), to prevent probable auto-oxidation processes. The sample temperature was 295 ± 2 K. The energy of the laser pulse was measured at each shot with a SPHD25 Scientech pyroelectric meter.
Singlet oxygen detection. Photogeneration of 1O2 upon laser excitation of the photosensitizer was monitored by luminescence measurements in oxygen-saturated solutions. The near-IR luminescence of singlet oxygen at 1.27 µm results from the forbidden transition 3g-1g; this was probed orthogonally to the exciting beam with a pre-amplified (low impedance) Ge-photodiode (Hamamatsu EI-P, 300 ns resolution) maintained at –196°C and coupled to a long-pass silicon filter (>1.1 m) and an interference filter (1.27 m). Pure signal of 1O2 were obtained as difference between signals in air- and Ar-saturated solutions. The temporal profile of the luminescence was fitted to a single-exponential decay function with the exclusion of the initial portion of the plot, which was affected by scattered excitation light, fluorescence, and the formation profile of singlet oxygen itself.
Nitric oxide detection. NO release was measured with a World Precision Instrument, ISO-NO meter, equipped with a data acquisition system, and based on direct amperometric detection of NO with short response time (< 5 s) and sensitivity range 1 nM–20 µM. The analog signal was digitalized with a four-channel recording system and transferred to a computer. The sensor was accurately calibrated by mixing standard solutions of NaNO2 with 0.1 M H2SO4 and 0.1 M KI according to the reaction:

4H+ + 2I- + 2NO2-  2H2O + 2NO + I2

Irradiation was performed in a thermostated quartz cell (1 cm path length, 3 mL capacity, 25°C) by using a 200 mW continuum laser with exc = 405 nm. NO measurements were carried out under stirring with the electrode positioned outside the light path in order to avoid NO signal artefacts due to photoelectric interference on the ISO-NO electrode.
Determination of fluorescence, triplet and 1O2 quantum yields. 
Fluorescence quantum yields were determined by using optically matched solution at the excitation wavelength of compounds 1 and 2 and aqueous solution of para-tetrakis(-methylpyridiniumyl)porphyrin as a standard (f = 0.047)33 through the following equation:
f =f (s) (In2/I(s)n2(s))

where f (s)  is the fluorescence quantum yield of the standard; I and I(s) are the areas of the fluorescence spectra of the compounds and the standard, respectively; n and n(s) are the refraction index of the solvents used for the compounds and the standard. In any case the absorbance at the excitation wavelength was less than 0.1.
Quantum yields for the triplet formation were determined by using optically matched solution at the excitation wavelength of compounds 1 and 2 and aqueous solution of the same standard as above (T = 0.92).33 The top A of the triplet signal from each sample was plotted as a function of the laser intensity. In this case the initial part of each set of data points is proportional to the product T  T-T, where T and T-T are the quantum yield of the triplet state and its molar absorption coefficient, respectively. By taking into account that all solutions are almost optically matched at the excitation wavelength and that large changes in the T-T are fairly unlikely, being substantially unchanged the band profiles, T values may be directly estimated by the different slopes () of the straight-lines obtained from the linear portion of the plots, via the simple equation; 
T= T(s)  / (s)

1O2 quantum yield were determined by using optically matched solution at the excitation wavelength of compounds 1 and 2 and 5,10,15,20-tetrakis(4-sulfonatophenyl)-21H,23H-porphyrin in D2O as a standard ( = 0.6).43 The luminescence of the 1O2 was recorded at different intensity of the laser pulse and the luminescence at initial time (L at t = 0) was extrapolated from the curve fitting. The values of L at t = 0, were then plotted against the laser intensity, and the related slopes () were compared. The values of  were determined by using the following equation: 
 = (s) /(s)

where (s) and  are the slopes of the plots of the 1O2 luminescence, determined at initial time against the energy of the laser pulse for the standard and the compounds, respectively.
Experiments with cells
American Type Culture Collection (Rockville, MD, USA) was maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (FCS), 2.0 mM L-glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin, and 25 µg/mL fungizone (Sigma–Aldrich, Italy), and incubated at 37 °C in humidified atmosphere containing 5% CO2. Cells from confluent cultures were detached using trypsin/EDTA and seeded in complete DMEM medium. For cell staining, the cells were cultured in 12-well culture dishes for 24 hours.  The medium was removed and replaced with medium without phenol red containing the solution of the sample for 4 hours. The cells were first washed with PBS, then fixed with 4% formaldehyde. After washing with PBS cells were incubated with 4,6-diamino-2-phenylindole (DAPI) (1:10,000; Invitrogen) for 10 min.
The photocytotoxicity experiments were carried out by irradiating the cells incubated either without or with the photoactive components with a 150 W Xe lamp through a cut-off filter at 400 nm. Cell proliferation was assessed by MTT assays, based on the conversion of a substrate containing a tetrazolium ring to spectrophotometrically detectable formazan by mitochondrial dehydrogenases. Briefly, cells were seeded at an initial density of 8 × 103 cells / microwell in flat-bottomed 200 µL microplates, incubated at 37 °C in a humidified atmosphere containing 5% CO2 for 24 hours. Subsequently, part of the cells were maintained as media controls while others were incubated with the photoactive compounds. In both cases complete DMEM without phenol red was used. Next, 20 µL of 0.5% 3-(4,5-dimethyl-thiazol-2-yl)2,5-diphenyl-tetrazolium bromide in PBS were added to each microwell. Following 4 h of incubation at 37 °C, the supernatant was removed and replaced with 100 µl of DMSO. The optical density of each well sample was measured with a microplate spectrophotometer reader (Digital and Analog Systems, Rome, Italy) at 550 nm. The cell viability (%) was calculated according to the following equation:

Cell Viability (%) = [ABefore – (AAfter / ABefore)] × 100

where, ABefore and AAfter are the absorbance values of the wells treated with samples before and after irradiation respectively. Each experiment was repeated at least three times in triplicate and the mean ± SEM for each value was calculated. Statistical analysis of results [Student’s t test for paired and unpaired data; variance analysis (ANOVA)] was performed using the statistical software package SYSTAT, version 11 (Systat Inc., Evanston IL, USA). A difference was considered significant at p < 0.05.
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